These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells. Honore S, Kamath K, Braguer D, Horwitz SB, Wilson L, Briand C, Jordan MA. Cancer Res; 2004 Jul 15; 64(14):4957-64. PubMed ID: 15256469 [Abstract] [Full Text] [Related]
3. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Kowalski RJ, Giannakakou P, Gunasekera SP, Longley RE, Day BW, Hamel E. Mol Pharmacol; 1997 Oct 15; 52(4):613-22. PubMed ID: 9380024 [Abstract] [Full Text] [Related]
8. Discodermolide analogues as the chemical component of combination bacteriolytic therapy. Smith AB, Freeze BS, LaMarche MJ, Sager J, Kinzler KW, Vogelstein B. Bioorg Med Chem Lett; 2005 Aug 01; 15(15):3623-6. PubMed ID: 15979874 [Abstract] [Full Text] [Related]
12. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin. Madiraju C, Edler MC, Hamel E, Raccor BS, Balachandran R, Zhu G, Giuliano KA, Vogt A, Shin Y, Fournier JH, Fukui Y, Brückner AM, Curran DP, Day BW. Biochemistry; 2005 Nov 15; 44(45):15053-63. PubMed ID: 16274252 [Abstract] [Full Text] [Related]
19. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation. Honore S, Kamath K, Braguer D, Wilson L, Briand C, Jordan MA. Mol Cancer Ther; 2003 Dec 12; 2(12):1303-11. PubMed ID: 14707271 [Abstract] [Full Text] [Related]